BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. , a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today announced results from a randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results